WEP CLINICAL PARTNERS WITH US BIOTECH COMPANY FOR THE NAMED PATIENT SUPPLY OF CANCER PRODUCT IN EX-US COUNTRIES Morrisville, NC, USA & London, UK – August 24, 2020 – WEP Clinical (WEP) announced today that, as [...]

WEP CLINICAL PARTNERS WITH BTG SPECIALTY PHARMACEUTICALS FOR EUROPEAN SUPPLY OF VORAXAZE® Morrisville, NC, USA & London, UK – July 1, 2020 – WEP Clinical (WEP) announced today that it has entered into a partnership with [...]

WEP CLINICAL PARTNERS WITH NABRIVA THERAPEUTICS FOR THE NAMED PATIENT SUPPLY OF XENLETA® (LEFAMULIN) Morrisville, NC, USA & London, UK – June 30, 2020 – WEP Clinical (WEP), a specialist pharmaceutical services company, has signed [...]

WEP CLINICAL JOINS WITH WREN HEALTHCARE TO PROVIDE HOME HEALTHCARE SERVICES Morrisville, NC, USA & London, UK – June 25, 2020 – WEP Group Holdings Limited (WEP), a specialist CRO focused on delivering lifesaving drugs to [...]

WEP CLINICAL PARTNERS WITH MYLAN TO PROVIDE PRODUCT FOR HIGHLY DRUG-RESISTANT TUBERCULOSIS Morrisville, NC, USA & London, UK – June 1, 2020 – WEP Clinical (WEP), the specialist pharmaceutical services company, has partnered with Mylan [...]

WEP CLINICAL LAUNCHES COVID-19 ANTIBODY TESTING SERVICE WEP Clinical (WEP), the specialist pharmaceutical services company, is committed to helping businesses cope with the current COVID-19 crisis. As part of these efforts, WEP has recently [...]

CORONAVIRUS STATEMENT – 16 MARCH 2020 WEP Clinical (“WEP”)’s management team met on 16 March 2020 to discuss the Coronavirus pandemic and agreed to invoke the Group’s Business Continuity plan. WEP believe that fast [...]

WEP CLINICAL AND WELLSTAT THERAPEUTICS CORPORATION ENTER INTO NEW PARTNERSHIP FOR THE NAMED PATIENT SUPPLY OF VISTOGARD® (URIDINE TRIACETATE) WEP Clinical, the specialist pharmaceutical services company, announces that it has signed an exclusive supply [...]